Angiogenesis is an essential process in normal development and in adult physiology, but
can be disrupted in numerous diseases. The concept of targeting angiogenesis for treating …

Diabetic retinopathy (DR) causes significant visual loss on a global scale. Treatments for the
vision-threatening complications of diabetic macular edema (DME) and proliferative diabetic …

Artificial Intelligence (AI) has long promised to increase healthcare affordability, quality and
accessibility but FDA, until recently, had never authorized an autonomous AI diagnostic …

Background: Diabetic retinopathy is a leading cause of visual impairment in working-age
adults worldwide. Duration of diabetes is a major risk factor associated with the development …

Diabetes retinopathy (DR) is a leading cause of vision loss in middle‐aged and elderly
people globally. Early detection and prompt treatment allow prevention of diabetes‐related …

The targeting of vascular endothelial growth factor A (VEGFA), a crucial regulator of both
normal and pathological angiogenesis, has revealed innovative therapeutic approaches in …

Purpose To review the current therapeutic options for the management of diabetic
retinopathy (DR) and diabetic macular edema (DME) and examine the evidence for …

Diabetic retinopathy is one of the most serious microvascular complications induced by
hyperglycemia via five major pathways, including polyol, hexosamine, protein kinase C, and …

Diabetic macular oedema, characterised by exudative fluid accumulation in the macula, is
the most common form of sight-threatening retinopathy in people with diabetes. It affects one …

Care of Patients with Diabetic Retinopathy Diabetic retinopathy is a leading cause of both
moderate and severe vision loss worldwide. Over the past decade, advances in technology …